Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 1
2(50.0%)
N/A
2(50.0%)
4Total
Phase 1(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07296822Not ApplicableRecruiting

Internet-Based Cognitive Behavioral Therapy for MRI-Related Anxiety

Role: collaborator

NCT05172232Completed

Diagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous Lesions

Role: collaborator

NCT05008042Phase 1Completed

Evaluation of the Efficiacy of Mecobalamine in the Treatment of Long-term Pain in Women Diagnosed With Fibromyalgia

Role: collaborator

NCT04605445Not ApplicableRecruiting

One Vs Two Visits Root Canal Treatments in Infected Teeth

Role: collaborator

NCT01986816Withdrawn

Return on Investment on Lap Gastric Bypass Regarding Quality of Life

Role: collaborator

NCT01987674Phase 1Terminated

Pre-meal Protein Drink Improve Glycemic Regulation

Role: collaborator

All 6 trials loaded